Stock listing
OTC:NPNKF Nippon Shinyaku Co., Ltd. Stock
US listing (OTC) of Nippon Shinyaku Co., Ltd. · home listing Tokyo:4516
Follow Nippon Shinyaku Co., Ltd. into a list and get an email when it puts out news.
- Ticker
- OTC:NPNKF
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Oct 29, 2026
Nippon Shinyaku Enters into Exclusive Sublicense Agreement with Tanabe Pharma to Commercialize loncastuximab tesirine-lpyl (MT-2111) for Relapsed or Refractory Diffuse Large B-cell Lymphoma in Japan
Latest deck · Mar 2, 2026
Technical Presentation (March 2026)
Technical · 39 slides
Latest news
Decks
Technical Presentation (March 2026)
Technical · 39 slides · Mar 2, 2026
Investor Presentation (March 2026)
Investor deck · 6 slides · Mar 2, 2026
Investor Day (February 2025)
Investor day · 59 slides · Feb 18, 2025
Investor Presentation (February 2025)
Investor deck · 19 slides · Feb 18, 2025
Nippon Shinyaku Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 19 in the last 12 months · 24 in all · newest Oct 29, 2026 · oldest 2025
- Decks
- 8 decks · latest Mar 2, 2026
Where Nippon Shinyaku Co., Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Tokyo:4516 日本新薬 · Home listing | Tokyo | Japan | JPY |
| OTC:NPPNY | OTC | United States | USD |
| OTC:NPNKF · This page | OTC | United States | USD |
| BIVA:4516N | BIVA | Mexico | MXN |
| BMV:4516N | BMV | Mexico | MXN |
Log in to ask 6ix AI your own questions about Nippon Shinyaku Co., Ltd.